0001415889-24-007243.txt : 20240307 0001415889-24-007243.hdr.sgml : 20240307 20240307214019 ACCESSION NUMBER: 0001415889-24-007243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moshkevich Solomon CENTRAL INDEX KEY: 0002010019 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 24732170 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 13011 MCCALLEN PASS, BLDG A, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-03072024_090309.xml X0508 4 2024-02-29 0001604821 Natera, Inc. NTRA 0002010019 Moshkevich Solomon C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 false true false false PRESIDENT, CLINICALDIAGNOSTICS 0 Common Stock 2024-02-29 4 A 0 3206 A 200512 D Common Stock 2024-03-05 4 S 0 18 87.3258 D 200494 D Common Stock 2024-03-05 4 S 0 2227 88.3650 D 198267 D On June 10, 2022, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 12,826 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 29, 2024, the achievement of milestones for the vesting of RSUs covering 3,206 shares of Common Stock was certified. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.31 to $87.3415 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Tami Chen, Attorney-in-Fact 2024-03-07